 Paul Christine
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 7 | 2024 | 413 | 2.930 |
Why?
| | Opiate Substitution Treatment | 4 | 2024 | 98 | 1.970 |
Why?
| | Buprenorphine | 4 | 2024 | 134 | 1.800 |
Why?
| | Residence Characteristics | 4 | 2018 | 275 | 1.470 |
Why?
| | Narcotic Antagonists | 2 | 2024 | 136 | 1.030 |
Why?
| | Environment Design | 2 | 2015 | 24 | 1.010 |
Why?
| | Medicaid | 3 | 2024 | 406 | 0.990 |
Why?
| | Insurance Coverage | 2 | 2024 | 200 | 0.980 |
Why?
| | Food Supply | 2 | 2015 | 64 | 0.960 |
Why?
| | Buprenorphine, Naloxone Drug Combination | 1 | 2024 | 9 | 0.920 |
Why?
| | Social Environment | 2 | 2015 | 283 | 0.890 |
Why?
| | Comparative Effectiveness Research | 1 | 2024 | 130 | 0.850 |
Why?
| | Naltrexone | 1 | 2024 | 83 | 0.850 |
Why?
| | Insurance, Health | 1 | 2024 | 244 | 0.800 |
Why?
| | Motor Activity | 2 | 2015 | 640 | 0.730 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2017 | 2094 | 0.630 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1177 | 0.520 |
Why?
| | Substance-Related Disorders | 2 | 2024 | 947 | 0.520 |
Why?
| | Social Class | 1 | 2017 | 204 | 0.520 |
Why?
| | Housing | 1 | 2016 | 114 | 0.510 |
Why?
| | Health Transition | 1 | 2014 | 7 | 0.480 |
Why?
| | Economic Development | 1 | 2014 | 3 | 0.480 |
Why?
| | Massachusetts | 2 | 2024 | 134 | 0.450 |
Why?
| | Atherosclerosis | 1 | 2017 | 341 | 0.440 |
Why?
| | Body Mass Index | 3 | 2018 | 1956 | 0.420 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2024 | 159 | 0.420 |
Why?
| | Group Processes | 1 | 2012 | 53 | 0.390 |
Why?
| | Social Identification | 1 | 2012 | 51 | 0.390 |
Why?
| | Blood Pressure | 2 | 2018 | 1538 | 0.380 |
Why?
| | Overweight | 1 | 2014 | 471 | 0.360 |
Why?
| | Longitudinal Studies | 4 | 2024 | 2387 | 0.340 |
Why?
| | Patient Participation | 1 | 2013 | 359 | 0.330 |
Why?
| | Middle Aged | 12 | 2024 | 26719 | 0.330 |
Why?
| | Education, Medical | 1 | 2012 | 215 | 0.330 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 668 | 0.310 |
Why?
| | Cross-Sectional Studies | 4 | 2024 | 4405 | 0.310 |
Why?
| | Students, Medical | 1 | 2012 | 262 | 0.300 |
Why?
| | Blood Glucose | 1 | 2016 | 1819 | 0.290 |
Why?
| | Socioeconomic Factors | 3 | 2016 | 1077 | 0.290 |
Why?
| | United States | 7 | 2024 | 12176 | 0.290 |
Why?
| | Humans | 25 | 2024 | 114624 | 0.280 |
Why?
| | Smoking | 4 | 2018 | 1380 | 0.280 |
Why?
| | Decision Making | 1 | 2013 | 782 | 0.260 |
Why?
| | Methadone | 2 | 2024 | 77 | 0.260 |
Why?
| | Male | 15 | 2024 | 55555 | 0.260 |
Why?
| | Female | 16 | 2024 | 59466 | 0.240 |
Why?
| | Analgesics, Opioid | 4 | 2024 | 771 | 0.240 |
Why?
| | Kentucky | 1 | 2024 | 35 | 0.240 |
Why?
| | Mifepristone | 1 | 2024 | 60 | 0.230 |
Why?
| | Diazepam | 1 | 2024 | 25 | 0.230 |
Why?
| | Interrupted Time Series Analysis | 1 | 2024 | 44 | 0.230 |
Why?
| | New York | 1 | 2024 | 106 | 0.230 |
Why?
| | Ohio | 1 | 2024 | 135 | 0.230 |
Why?
| | Observational Studies as Topic | 1 | 2024 | 90 | 0.220 |
Why?
| | Benzodiazepines | 1 | 2024 | 116 | 0.220 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1075 | 0.220 |
Why?
| | Delayed-Action Preparations | 1 | 2024 | 159 | 0.220 |
Why?
| | Naloxone | 1 | 2024 | 97 | 0.220 |
Why?
| | Abortion, Induced | 1 | 2024 | 71 | 0.210 |
Why?
| | Drug Overdose | 2 | 2024 | 292 | 0.210 |
Why?
| | Obesity | 1 | 2014 | 2507 | 0.200 |
Why?
| | Aged, 80 and over | 4 | 2016 | 6344 | 0.190 |
Why?
| | Adult | 8 | 2024 | 30528 | 0.190 |
Why?
| | Aged | 7 | 2021 | 19061 | 0.180 |
Why?
| | Endocarditis, Bacterial | 1 | 2021 | 36 | 0.180 |
Why?
| | Young Adult | 5 | 2024 | 10455 | 0.170 |
Why?
| | Risk Factors | 3 | 2017 | 8628 | 0.160 |
Why?
| | Economic Recession | 1 | 2018 | 5 | 0.160 |
Why?
| | Unemployment | 1 | 2018 | 39 | 0.160 |
Why?
| | Research Design | 1 | 2024 | 928 | 0.150 |
Why?
| | Argentina | 2 | 2014 | 14 | 0.150 |
Why?
| | Adolescent | 5 | 2024 | 17831 | 0.140 |
Why?
| | Patient Care Team | 1 | 2021 | 517 | 0.130 |
Why?
| | Alcohol Drinking | 2 | 2018 | 651 | 0.130 |
Why?
| | Pandemics | 1 | 2023 | 1317 | 0.130 |
Why?
| | Geographic Information Systems | 1 | 2015 | 37 | 0.120 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2016 | 71 | 0.120 |
Why?
| | Smoke-Free Policy | 1 | 2015 | 13 | 0.120 |
Why?
| | Prospective Studies | 2 | 2017 | 6217 | 0.120 |
Why?
| | Public Opinion | 1 | 2015 | 59 | 0.120 |
Why?
| | China | 1 | 2015 | 161 | 0.120 |
Why?
| | Models, Psychological | 1 | 2016 | 296 | 0.120 |
Why?
| | Behavior | 1 | 2015 | 92 | 0.120 |
Why?
| | Spatio-Temporal Analysis | 1 | 2014 | 25 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2016 | 1226 | 0.110 |
Why?
| | Nutrition Surveys | 1 | 2014 | 224 | 0.110 |
Why?
| | Mental Health | 1 | 2018 | 562 | 0.110 |
Why?
| | Amnion | 1 | 2013 | 24 | 0.110 |
Why?
| | Health Behavior | 1 | 2018 | 704 | 0.110 |
Why?
| | Potassium Channels, Calcium-Activated | 1 | 2012 | 9 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2016 | 374 | 0.100 |
Why?
| | Premature Birth | 2 | 2013 | 276 | 0.100 |
Why?
| | Prevalence | 2 | 2016 | 2249 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2012 | 93 | 0.100 |
Why?
| | Science | 1 | 2012 | 48 | 0.100 |
Why?
| | Research Support as Topic | 1 | 2012 | 108 | 0.100 |
Why?
| | Genetic Association Studies | 1 | 2013 | 339 | 0.090 |
Why?
| | Physician's Role | 1 | 2012 | 197 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 319 | 0.090 |
Why?
| | Sex Factors | 1 | 2014 | 1715 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2311 | 0.080 |
Why?
| | DNA Methylation | 1 | 2013 | 495 | 0.080 |
Why?
| | Physician-Patient Relations | 1 | 2013 | 462 | 0.080 |
Why?
| | Risk Assessment | 1 | 2017 | 2967 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 1727 | 0.070 |
Why?
| | Communication | 1 | 2013 | 744 | 0.070 |
Why?
| | Cohort Studies | 1 | 2015 | 4894 | 0.060 |
Why?
| | Hostility | 1 | 2024 | 13 | 0.060 |
Why?
| | Minnesota | 1 | 2023 | 134 | 0.050 |
Why?
| | Health Policy | 1 | 2024 | 334 | 0.050 |
Why?
| | Propensity Score | 1 | 2021 | 224 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 2024 | 761 | 0.040 |
Why?
| | Pregnancy | 2 | 2024 | 5517 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2021 | 776 | 0.030 |
Why?
| | Educational Status | 1 | 2018 | 412 | 0.030 |
Why?
| | Mexico | 1 | 2015 | 162 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 580 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 1815 | 0.030 |
Why?
| | Receptors, Oxytocin | 1 | 2013 | 23 | 0.030 |
Why?
| | Indians, South American | 1 | 2012 | 22 | 0.030 |
Why?
| | CpG Islands | 1 | 2013 | 117 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 2013 | 52 | 0.030 |
Why?
| | Tobacco Smoke Pollution | 1 | 2015 | 217 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 175 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2013 | 5043 | 0.020 |
Why?
| | Cation Transport Proteins | 1 | 2013 | 123 | 0.020 |
Why?
| | Genetic Loci | 1 | 2013 | 262 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2012 | 338 | 0.020 |
Why?
| | DNA, Mitochondrial | 1 | 2012 | 182 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 740 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2018 | 944 | 0.020 |
Why?
| | Depression | 1 | 2018 | 1133 | 0.020 |
Why?
| | Gestational Age | 1 | 2013 | 759 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 610 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 520 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1131 | 0.020 |
Why?
| | Fetus | 1 | 2012 | 699 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1644 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1760 | 0.020 |
Why?
| | Placenta | 1 | 2013 | 625 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1518 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 1879 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2084 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 4620 | 0.010 |
Why?
|
|
Christine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|